Although there were no associations between Treg and tumor stage or histological differentiation, Treg percentage inversely correlated with that of total CD8+ T cells in cancer patients and was associated with inhibition of cytokine expression in CTLs suggesting a possible role in the downregulation of antitumor immune response. The gene discussed is CD8A; the disease is neoplasm.